• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC NOVASURE; DEVICE, THERMAL ABLATION, ENDOMETRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC NOVASURE; DEVICE, THERMAL ABLATION, ENDOMETRIAL Back to Search Results
Model Number 2013
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Bacterial Infection (1735)
Date of Event 08/06/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A device history record (dhr) review was conducted for the reported lot/serial number.The device was released meeting all qa specifications.The device involved in this event was not returned for evaluation purposes therefore visual and functional analysis of the product could not be performed.We are unable to confirm a relationship between the device and the issue reported.The information obtained during complaint investigation will be included in our global complaint trending and product surveillance will continue to monitor complaints of this type for adverse trends.If the product is received or additional information is obtained, the investigation will be reopened accordingly per standard operating procedure.
 
Event or Problem Description
It was reported on august 6th, 2025 that the physician used two novasure devices.The first device used received a vacuum alarm after the collection cannister filled with blood and the second device was used to complete the procedure.After 12 hours post procedure the patient was experiencing fever and chills.A culture was performed and it was confirmed after 48 hours that the patient had a group b streptococcus sepsis.The patient is in good condition and was released on (b)(6) 2025 after receiving intravenous antibiotics.No other information available.
 
Additional Manufacturer Narrative
Device was returned: visual inspection was conducted, and the desiccant filter and the big filter were both filled with fluid.Functional testing was conducted and the cia test failed, the leak test was performed, and no leaks were observed, the desiccant filter and the big filter were replaced and the cia test passed, and the procedure was completed.Hence, the complaint confirmed that the filter occluded thus leading to the vacuum alarm.This observation will be monitored and trended.A device history record (dhr) review was conducted for the reported lot/serial number.The device was released meeting all qa specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVASURE
Common Device Name
DEVICE, THERMAL ABLATION, ENDOMETRIAL
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer (Section G)
HOLOGIC, INC.
250 campus drive
marlborough MA 01752
Manufacturer Contact
simran keswani
250 campus drive
marlborough, MA 01752
MDR Report Key22805259
Report Number1222780-2025-00441
Device Sequence Number15719178
Product Code MNB
UDI-Device Identifier15420045501119
UDI-Public(01)15420045501119(17)270306(10)25B14RK
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
P010013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number2013
Device Catalogue NumberNS2013KITUS
Device Lot Number25B14RK
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/06/2025
Supplement Date Received by Manufacturer08/14/2025
10/02/2025
Initial Report FDA Received Date08/14/2025
Supplement Report FDA Received Date08/14/2025
10/17/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/14/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other;
Patient SexUnknown
-
-